Germany· DE-A57-286c7cd2cb88686b

Perenterol Derm

A saccharomyces boulardii product containing saccharomyces boulardii, registered in Germany by Biocodex. The same ATC class is registered in 10 of our 19 countries.

ATC A07FA02

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedPerenterol DermATCA07FA02REGISTER NO.DE-A57-286c7cd2cb8868…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Saccharomyces boulardii is registered in 10 of 19 countries.

Countries holding a registration under ATC A07FA02 (saccharomyces boulardii), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 7 of them publish a price we can compare per daily dose

Saccharomyces boulardii · ATC A07FA02

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of saccharomyces boulardii costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Saccharomyces boulardii · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$4.16
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Saccharomyces Boulardii
Manufacturer
Biocodex
Country
Germany (DE)
ATC code
A07FA02
ATC class
Saccharomyces boulardii
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Saccharomyces boulardii in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All saccharomyces boulardii products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Yomogi
  • Belgium · Sacchiflora
  • Cyprus · Bioflor
  • Italy · Codex, Preparazione H
  • Portugal · Prolif
  • Sweden · Precosa
  • Slovakia · Yomogi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/497e1080-d7b9-4c1a-823a-2f153442fe6f
GET /v1/drugs/497e1080-d7b9-4c1a-823a-2f153442fe6f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Saccharomyces Boulardii",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about saccharomyces boulardii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.